Srihari Gopal, based in Belle Mead, NJ, is a prominent inventor in the field of pharmaceutical sciences. With a remarkable record of 13 patents, Gopal has made significant contributions to the development of innovative treatments, particularly in injectable formulations and pharmaceutical compositions.

Latest Patents

Among his most recent patents is the invention titled "Dosing regimens associated with extended release paliperidone injectable formulations." This invention outlines a method for treating patients using long-acting injectable paliperidone palmitate formulations. Another noteworthy patent is titled "Compositions comprising aticaprant," which includes oral compositions in the form of tablets that consist of aticaprant and describes methods for their use. These innovations reveal his dedication to improving patient care through advanced drug delivery systems.

Career Highlights

Srihari Gopal has had a distinguished career, having worked with several leading pharmaceutical companies. Notably, he has been associated with Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV, where he has played a pivotal role in research and development. His expertise in pharmaceutical sciences has enabled him to develop patented solutions that significantly enhance therapeutic outcomes for patients.

Collaborations

Throughout his career, Gopal has collaborated with talented professionals, including notable coworkers such as Adam Savitz and Mark Schmidt. These collaborations have fostered an environment of innovation and excellence in pharmaceutical research, further highlighting the importance of teamwork in achieving groundbreaking advancements.

Conclusion

Srihari Gopal's contributions to the field of pharmaceutical sciences, through his 13 patents, underline his impactful role as an inventor. His latest innovations in injectable formulations and oral compositions showcase his commitment to enhancing medical treatments. As he continues to push the boundaries of pharmaceutical research, Gopal stands as a testament to the power of innovation in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.